The company's science concerns the importance of phytochemicals in our daily diet. While most of us recognize the value of herbs and botanical products, our product offerings work within a new (patent-pending) therapeutic and predictive model that was developed by Chip Paul, Head of Nutrecs ECS Neurology Department.

You need unique plant based resources to be healthy and happy. Without them, our bodies begin to break down along genetic or trauma pathways. With them, we see that the body has an amazing ability to heal itself. Especially when used for the purpose ECS Functional Neurology. Functional Neurology is on the cutting edge of DC healthcare and when merging such technolohy with endocannabinoid science (the newest and one of the most important brain discoveries in the MD history), their merge offers dose bases system to resolve patient symptoms like never experienced before. In the future, we feel that natural ECS, Nano and neurological approaches to healthcare will continue to gain ground and outperform Pharma synthetic option. 
The science of Nano & the Endocannabinoid system marks the beginning of a whole new approach to diagnosing and treating disease with natural herbal and botanical substances.



Neurological Precursors

NANO Technology

ECS Neurology

Phytochemical's

Adaptogens

Flavinoids

Nutrecs areas of development and product availability

  

Cancer, Pain, Fibromyalgia, Opiate Addiction, Hormones, Menopause, Thyroid, Immunity, Cardiovascular, Obesity, Mood, Anxiety, Depression, Stress, Aging, Inflammation, Regenerative Sleep, Energy, ADHD and FocusType your paragraph here.

The different terms reflect the business and technological roots of the industry, and often the particular background of the writer.

The pharmaceuticals industry ("Pharma") grew up starting with the synthesis of aspirin in 1897 by Felix Hoffmann, a chemist at Bayer, which led to the first large-scale commercially manufactured drug.  (See Aspirin, and Bayer.)   

The area of Germany where Bayer was formed in the late 1800's is sometimes referred to as the 'Silicon Valley of industrial chemistry,' and aspirin, like most early drugs, is a relatively simple 'small molecule' that is manufactured using industrial synthesis technology.  A typical pharmaceutical manufacturing plant looks much like any other industrial chemical facility.


By contrast, the biotechnology industry ("Biotech") was launched in 1976 in Silicon Valley, starting with the development of human insulin by Genentech (a portmanteau of genetics, engineering, and technology).  Genentech was founded by venture capitalist Robert Swanson and biochemist Herbert Boyer from UCSF to commercialize the new technology of of recombinant DNA. 

Recombinant DNA makes changes to the DNA of living cells, changing their internal biochemical pathways in order to have them produce molecules of interest.  Biotech drugs are typically proteins of various sorts, and tend to be very complex 'large molecules.'  Because the manufacturing process typically consists of growing large batches of cells in a nutritive medium, and then filtering out the molecule of interest, the inside of a biotech plant looks more like a high-tech brewery than a process plant.


While the pharma industry has moved even further into man made synthesized drugs, companies like Nutrecs have moved entirely into natural & organic bio sciences with intent to deliver products that offer symptom resolution in a safer and more effective manner than pharmaceutical options.

What is the difference between BioPharma and Pharma?